What we do Unjha Formulations Ltd manufactures pharmaceutical and Ayurvedic products, specializing in Isabgol-based formulations for human and veterinary use. |
Founded in 1,987 |
Market share One of India's largest manufacturers of Isabgol products with a strong domestic presence and growing export markets. |
Problem solved Provides quality Isabgol Ayurvedic formulations addressing digestive health and veterinary needs. |
Top clients or who we serve B2B partnerships with major pharmaceutical companies; serves both human and veterinary healthcare markets. |
Key management - |
Our journey and innovations Established in 1987; pioneered Isabgol formulations; expanded product range and export markets; manufacturing agreements with reputed firms. |
Where we operate Primarily India with export markets including South America and Middle East. |
Top products or what we offer Isabgol powders, tablets, capsules, veterinary products, and newer launches like Bericof and Formentin tablets. |
Top brands FYBOGEL (Isabgol Husk product) under manufacturing agreement; Fibron SF Powder and Fibermato exported internationally. |
Raw materials needed Isabgol Husk and Isabgol Powder primarily. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue mainly from manufacturing contracts and exports, recurring but influenced by market demand. |
Our industry position Leading player in Isabgol formulations; strong GMP-certified manufacturing capabilities with established pharma partnerships. |
Financial highlights FY 2020-21 revenue ₹9.96 Cr; net profit ₹0.10 Cr; pending recovery post COVID-19 impact; growth focus on export markets. |
Geographical revenue split Predominantly India with exports to South America and Middle East regions. |
Order book - |
Whats driving growth Growing health awareness, export market development, and contract manufacturing agreements. |
Our future plans Expand export portfolio and launch new Ayurvedic formulations to boost sales and diversify products. |
Our green promise - |
Our people and values Committed workforce maintaining GMP standards and ethical business practices. |
Key challenges ahead Domestic demand challenges, COVID-19 disruptions, and competitive pharmaceutical market pressures. |
Interesting facts Pioneer in Isabgol formulations; has manufacturing tie-ups with leading Indian pharmaceutical firms. |
Risks and strategy Mitigating market risk via export focus and contract manufacturing to maintain steady revenue. |
